Multipotent mesenchymal stem cells in lung fibrosis.

about

Correction: Multipotent mesenchymal stem cells in lung fibrosis.Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.

P2860

Q48518724-782E6AD0-58FB-42F8-86B5-D559DE703665 Q55379594-6E4F3BED-F1FE-4EE7-9BED-4BBCE5664B3B

P2860

Multipotent mesenchymal stem cells in lung fibrosis.

Item

http://www.wikidata.org/entity/Q41474873

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multipotent mesenchymal stem cells in lung fibrosis.

@en

type

Item

label

Multipotent mesenchymal stem cells in lung fibrosis.

@en

prefLabel

Multipotent mesenchymal stem cells in lung fibrosis.

@en

P1476

Multipotent mesenchymal stem cells in lung fibrosis.

@en

P2093

Didier Lardinois

http://www.w3.org/2001/XMLSchema#string

Michael Tamm

http://www.w3.org/2001/XMLSchema#string

Petra Khan

http://www.w3.org/2001/XMLSchema#string

Spasenija Savic

http://www.w3.org/2001/XMLSchema#string

Thomas Geiser

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Localization of bone marrow stromal cells to the injury site after intracerebral hemorrhage in rats.

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Stem cells and cell therapy approaches in lung biology and diseases.

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.

P304

e0181946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181946

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28827799

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5565112

http://www.w3.org/2001/XMLSchema#string

Multipotent mesenchymal stem cells in lung fibrosis.

about

P2860

P2860

Multipotent mesenchymal stem cells in lung fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932